Search

everythinglearnresearchcommunity

for

Search:↓

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Androgens can both increase and decrease hair growth in different parts of the body.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Combining biomaterials and cell pathways can improve hair follicle regeneration.

Optical Coherence Tomography has potential in diagnosing hair loss and monitoring blood clotting, and could be improved for deeper tissue observation and better hair loss understanding.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Fat-derived stem cells may help treat skin aging and hair loss.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.